Lung cancer vaccine MAGE-A3 does not improve disease-free survival in resected lung cancer
At ESMO 2014, Prof Johan F. Vansteenkiste presents the results of a phase III trial (MAGRIT). The results show that MAGE-A3 cancer immunotherapy in patients with resected NSCLC does not increase disea...
Author: EMJ
Added: 10/03/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Lung Cancer | Non-Small Cell Lung Cancer | Vaccines